Neonc Technologies (NASDAQ:NTHI) CEO Amir Heshmatpour Acquires 20,000 Shares of Company Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour acquired 20,000 shares of the business’s stock in a transaction dated Wednesday, November 11th. The stock was acquired at an average price of $4.25 per share, for a total transaction of $85,000.00. Following the purchase, the chief executive officer directly owned 3,333,000 shares of the company’s stock, valued at approximately $14,165,250. This trade represents a 0.60% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Neonc Technologies Stock Performance

Shares of NTHI opened at $4.85 on Friday. Neonc Technologies Holdings, Inc. has a 52 week low of $2.50 and a 52 week high of $11.81. The stock’s 50-day moving average price is $3.30 and its 200-day moving average price is $5.29.

Neonc Technologies (NASDAQ:NTHI) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.03).

Institutional Investors Weigh In On Neonc Technologies

A number of institutional investors have recently modified their holdings of the company. Bank of America Corp DE lifted its holdings in Neonc Technologies by 5.0% during the 1st quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock worth $1,650,000 after buying an additional 11,108 shares in the last quarter. Westmount Partners LLC grew its stake in shares of Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after acquiring an additional 153,858 shares in the last quarter. BlackRock Inc. acquired a new position in shares of Neonc Technologies in the second quarter worth $815,000. Finally, Global Retirement Partners LLC acquired a new position in shares of Neonc Technologies in the second quarter worth $126,000.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on NTHI shares. Zacks Research raised shares of Neonc Technologies from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 5th. BTIG Research restated a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a research report on Tuesday, September 8th. Wall Street Zen raised Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Roth Capital assumed coverage on Neonc Technologies in a report on Thursday, September 24th. They issued a “buy” rating for the company. Finally, Weiss Ratings downgraded Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, October 21st. Four research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $16.00.

Neonc Technologies Company Profile

NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.